Biocodex
Gentillybiocodex.com
Overview
Biocodex is an independent multinational pharmaceutical company that operates as a corporate venture investor, focusing on innovative therapeutics involving probiotics or microbial strains, microbiota care, women's health, and orphan diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Next-Microbiome | Oct 2025 | Series A Extension | Lead |
| Exeliom Biosciences | Oct 2025 | Series A Extension | Lead |
| MRM Health | Sep 2025 | Series B | Lead |
| Exeliom Biosciences | Jul 2023 | Series A Extension | Co-investor |
| Next-Microbiome | Jun 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
